Therapeutic Asset Ratings

3,186 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Anti-Bcma Car-T Plasma Cell Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	D (19)
Bcma-Cd19 Ccar T Cells Behcet Disease	Peking University People's Hospital	P2	D (19)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes Pancreatic Neuroendocrine Tumor	Anusha Kalbasi	P1	D (19)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells Nodal Marginal Zone B-Cell Lymphoma	City of Hope Medical Center	P1	D (19)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells Refractory Hairy Cell Leukemia	City of Hope Medical Center	P1	D (19)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells Splenic Marginal Zone Lymphoma	City of Hope Medical Center	P1	D (19)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes Hairy Cell Leukemia	City of Hope Medical Center	P1	D (19)
Autologous Mesothelin-Specific Tcr-T Cells Malignant Pancreatic Neoplasm	Fred Hutchinson Cancer Center	P1	D (19)
Autologous Muc1-Activated T-Cells Primary Peritoneal Carcinoma	Mayo Clinic	P1	D (19)
b7-h3-car t cells Ependymoma	St. Jude Children's Research Hospital	P1	D (19)
cd22 car-t Waldenstrom Macroglobulinemia	Stanford University	P1	D (19)
her2bbζ/cd19t+ t cells Grade III Glioma	City of Hope Medical Center	P1	D (19)
Super1 Tcr-T Lung Cancer	Guangzhou FineImmune Biotechnology Co., LTD.	P1	D (19)
Super1 Tcr-T Sarcoma	Guangzhou FineImmune Biotechnology Co., LTD.	P1	D (19)
Tc-N201 Cells Cancer	TCRCure Biopharma Ltd.	P1	D (19)
Wu-Cart-007 Mycosis Fungoides	Washington University School of Medicine	P1	D (19)
Bcma Car T Cells Amyloidosis	Zhejiang University	Early P1	D (19)
Human Bcma Targeted Car-Nk Cells Plasma Cell Leukemia	Hrain Biotechnology Co., Ltd.	Early P1	D (19)
Metabolically Armed Bcma Car-T Cells. Plasma Cell Leukemia	Anhui Provincial Hospital	Early P1	D (19)
4scar dll3 t cells Glioblastoma	Shenzhen Geno-Immune Medical Institute	P1/2	D (19)
a2b694 Lung Cancer	A2 Biotherapeutics Inc.	P1/2	D (19)
a2b694 Malignant Mesothelioma	A2 Biotherapeutics Inc.	P1/2	D (19)
a2b694 Non-Small Cell Squamous Lung Carcinoma	A2 Biotherapeutics Inc.	P1/2	D (19)

Showing 2901 to 2925 of 3,186 assets

PreviousPage 117 of 128Next